phase iii findings for lenvatinib in hcc
Published 7 years ago • 345 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
1:22
dr. cheng on phase iii findings of lenvatinib in hcc
-
1:40
comparing sorafenib and lenvatinib for the frontline treatment of advanced hcc
-
58:25
molecular targeted therapies for advanced hcc
-
1:33
adverse events inform treatment decisions in hcc for frontline lenvatinib versus sorafenib
-
4:55
treatment approach to metastatic hepatocellular carcinoma
-
1:22
discussing the phase ii study of lenvatinib/pembrolizumab in metastatic ccrcc
-
1:46
results from the celestial trial for patients with advanced hcc
-
1:38
dr. abou-alfa on adjuvant sorafenib for the treatment of hcc (phase iii storm trial)
-
6:08
imbrave150 trial: combination therapy in advanced hcc
-
4:33
results from a phase iii study of sorafenib and sbrt for hepatocellular carcinoma
-
1:05
new agents shake up treatment landscape for patients with hcc
-
1:17
advice on decision making for frontline treatment of hcc
-
0:41
keystep-004: combination immunotherapy with lenvatinib for advanced hcc
-
1:00
lenvatinib in thyroid cancer with and without vegf-targeted therapy
-
2:31
dr. bruix on the phase iii resorce trial in hcc
-
2:56
dr. finn on role of lenvatinib in hcc treatment paradigm
-
6:53
sequencing in dtc: lenvatinib and sorafenib
-
7:24
practical considerations for using lenvatinib in hcc